Garde Capital’s GSK GSK Stock Holding History

Garde Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,318	Closed	-$50.6K	–	483
2025 Q2	$50.6K	Hold	1,318	–	–	﹤0.01%	348
2025 Q1	$51.1K	Buy	+1,318	New	+$48.3K	﹤0.01%	337

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Garde Capital's GSK Position: Q3 2025 in Review

Garde Capital sold out of GSK (GSK) in Q3 2025, closing a stake of 1,318 shares — an estimated $50.6K sold.

Garde Capital first reported a position in GSK in Q1 2025 and held it in 2 quarters. The position peaked at $51.1K in Q1 2025. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Garde Capital reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 1,318 GSK shares in Q3 2025, an estimated $50.6K.
Garde Capital first reported a position in GSK in Q1 2025 and held it in 2 quarters.
Garde Capital's GSK position peaked at $51.1K in Q1 2025.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.